期刊文献+

辛伐他汀降脂治疗冠心病的疗效观察 被引量:4

Simvastatin lipid-lowering efficacy of treatment of coronary artery disease observed
下载PDF
导出
摘要 目的观察辛伐他汀降低冠心病患者血脂的疗效。方法59例冠心病患者给予辛伐他汀20mg,1次/d,连续口服3个月。治疗前后分别检测血清胆固醇(TC)、低密度脂蛋白(LDL-C)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)。结果治疗后各项血脂指标均较治疗前有显著降低(P均<0.01),不良反应未见明显增加(P均>0.05)。结论辛伐他汀能有效降低TC、LDL-C、TG、HDL-C且具有较高的安全性。 Objective To observe simvastatin to lower serum lipids in patients with coronary heart disease treatment. Methods 59 cases of coronary heart disease patients given simvastatin 20 rag, day 1, continuous oral administration for 3 months. Before and after treatment were used to detect the serum cholesterol ( TC), low density lipoprotein (LDL-C), triglycerides (TG), high density lipoprotein cholesterol (HDL-C). Results after treatment of the blood lipid indicators than those before treatment has significantly reduced (P 〈 0. 01 ), no significant increase in adverse reactions (P 〉 0.05 ). Conclusion Simvastatin can effectively reduce tiC, LDL-C, TG, HDL-C and has a higher security.
出处 《中国实用医药》 2009年第31期22-23,共2页 China Practical Medicine
关键词 辛伐他汀 冠心病 血脂 Simvastatin Coronary heart disease Lipid
  • 相关文献

参考文献5

二级参考文献24

  • 1王海艳,郝玉明,李涛,崔炜,刘凡,谢文丽,郑红梅.冠心病患者周围动脉内膜-中层厚度的研究[J].中国心血管杂志,2004,9(4):282-282. 被引量:12
  • 2范晓红,王春.颈动脉粥样硬化的发病情况及其影响因素的调查与相关分析[J].中华心血管病杂志,2006,34(2):174-175. 被引量:80
  • 3Terje R, Pedersen TR. Lars Wilhelmsen, et al. Scandinavian Simvastatin Survival Study Group. Randomized trial of chplesterol lowering in 4 444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study(4S) [J]. Lancet, 1994,344:1383-1389
  • 4The long-term intervention with pravastatin in ischaemic chsease (LIPID)study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels[J] .N Engl J Ned. 1998,339:1349-1357.
  • 5Deskur-Smielecka E, Wykr Towicz A. The influence of short-term treatment with simvastatin on the inflammatory profile of patients with hyper-cholesterolemia[J] .Coronn Artery Dis,2001,12:143-148.
  • 6Santos AF, Kifel E. Safety and efficacy' of simvastatin for hyperlipidemia in renal transplant recipients: a double-blind, randomized, placebocontrolled stutly [J] .Transplant Proc, 200 L,B3 : 1194-1195.
  • 7Pedersen TR. Pro and con: low-density lipoprotein cholesterol lowing is and will be the key to the future of lipid management[J].Am J Cardiol,2001,8:27(5A) :8B-12B.
  • 8Yamasaki Y, Kodmna M, Nishizawa H, et al. Carotid intima-media thinckness in Japanese type 2 diabetic subjects: predictiors of progression and relationship with incident coronary heart disease [J]. Diabetes Care ,2000,23 (9) : 1310 - 1315.
  • 9Ghiadoni L, Taddei S, Vixdis A. Endothelial function and common carotid artery wall thickening in patients with essential hypertension [J]. Hypertension ,1998,32( 1 ) :25 -32.
  • 10Holaj R, Spacil J, Petrasek J,et al. Relation of the thickness of the intima and media of the common carotid artery, atherosclerotic plaque in the carotids and manifestations of atherosclerosis in the vessels of the lower extremity in comparison to coronary atherosclerosis [J]. Cas Lek Cesk,1998,137(23) :716 -720.

共引文献3103

同被引文献14

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部